🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 84 of 99

  1. TD-9855

    Theravance Biopharma Ireland Umited

    Drug Drug Interaction (DDI)

    phase 1 small molecule completed

    1 trial

  2. TDV - Low Dose

    Takeda

    Dengue Fever

    phase 1 mab completed

    1 trial

  3. TEV-48125 - 1

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  4. TEV-53408

    Teva Pharma GmbH

    Vitiligo

    phase 1 small molecule active

    1 trial

  5. TEV-56278

    Teva Pharma GmbH

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  6. TEV-56286

    Teva Pharma GmbH

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  7. TEV-56286 Test

    Teva Pharma GmbH

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  8. TG-0054

    Structure Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  9. TG-1701

    TG THERAPEUTICS, INC.

    Non Hodgkin Lymphoma

    phase 1 small molecule terminated

    1 trial

  10. TG-1801

    TG THERAPEUTICS, INC.

    B-Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  11. TG-1801

    TG THERAPEUTICS, INC.

    CLL

    phase 1 mab terminated

    1 trial

  12. TGD001 SAD study in healthy volunteers

    Lacuna Pharma Pty Ltd

    A Phase I randomized, double-blind, placebo-controlled study to assess the safety and pharmacokinetics of single-ascending doses of TGD001 in healthy volunteers

    phase 1 other active

    1 trial

  13. TGI-5

    TG THERAPEUTICS, INC.

    CRC (Colorectal Cancer)

    phase 1 small molecule active

    1 trial

  14. TGI-6 Injection

    TG THERAPEUTICS, INC.

    Advanced or Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  15. TGR-1202

    TG THERAPEUTICS, INC.

    Non-Hodgkin's Lymphoma

    phase 1 small molecule completed

    1 trial

  16. TGR-1202

    TG THERAPEUTICS, INC.

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  17. TGR-1202

    TG THERAPEUTICS, INC.

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 1 small molecule completed

    1 trial

  18. TGR-1202 + Obinutuzumab + Chlorambucil

    TG THERAPEUTICS, INC.

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  19. TGR-1202 + brentuximab vedotin

    TG THERAPEUTICS, INC.

    Hodgkin's Lymphoma

    phase 1 small molecule completed

    1 trial

  20. TH-SC01(Umbilical cord mesenchymal stem cells)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Injury

    phase 1 mab active

    1 trial

  21. TH1902

    WINDTREE THERAPEUTICS INC /DE/

    Solid Tumor

    phase 1 small molecule active

    1 trial

  22. THC

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  23. THC 30mg

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 small molecule active

    1 trial

  24. THC High Dose

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 small molecule active

    1 trial

  25. TI-0010

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    phase 1 mab active

    1 trial

  26. TIL

    Iovance Biotherapeutics B.V.

    Sarcoma

    phase 1 small molecule completed

    1 trial

  27. TKM-100201

    Arbutus Biopharma Corp

    Ebola Virus Infection

    phase 1 small molecule terminated

    1 trial

  28. TKM-100802 for Injection

    Arbutus Biopharma Corp

    Ebola Virus Infection

    phase 1 small molecule terminated

    1 trial

  29. TL011

    Teva Pharma GmbH

    DLBCL

    phase 1 mab completed

    1 trial

  30. TL011, anti CD20, for the treatment of rheumatoid arthritis

    Teva Pharma GmbH

    Rheumatoid Arthritis

    phase 1 mab completed

    1 trial

  31. TMC207

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  32. TMS (MagVenture MagPro 100 with MagOption)

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 other active

    1 trial

  33. TN-401

    Tenaya Therapeutics

    Arrhythmogenic Right Ventricular Cardiomyopathy

    phase 1 gene therapy active

    1 trial

  34. TNP-2092 capsules

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule completed

    1 trial

  35. TNX-102 SL

    Tonix Pharmaceuticals Holding

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  36. TNX-102 SL

    Tonix Pharmaceuticals Holding

    Healthy Subjects (HS)

    phase 1 small molecule completed

    1 trial

  37. TNX-102 SL 5.6 mg

    Tonix Pharmaceuticals Holding

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  38. TNX-102 SL Tablet

    Tonix Pharmaceuticals Holding

    Pharmakokinetic

    phase 1 small molecule active

    1 trial

  39. TNX-102 SL Tablets at 2.8 mg

    Tonix Pharmaceuticals Holding

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  40. TNX-1500

    Tonix Pharmaceuticals Holding

    Phase 1 First-in-human Study Involving Healthy Subjects

    phase 1 small molecule completed

    1 trial

  41. TNX-201 35 mg

    Tonix Pharmaceuticals Holding

    Healthy

    phase 1 small molecule completed

    1 trial

  42. TNX-2110

    Tonix Pharmaceuticals Holding

    Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

    phase 1 mab terminated

    1 trial

  43. TP-03 (Lotilaner Ophthalmic Solution), 0.25%

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  44. TP-05 (lotilaner oral capsules)

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  45. TP-05 (lotilaner oral), fasted group

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  46. TPST-1495 twice daily

    Tempest Therapeutics

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  47. TQB2101 for Injection

    Nanjing Zenshine Pharmaceuticals

    Advanced Hematologic Malignancies

    phase 1 small molecule active

    1 trial

  48. TQB2825 Injection (Subcutaneous Injection)

    Shanghai University of Traditional Chinese Medicine

    CD20-positive Hematological Malignancies

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.